Skip to main content

Sounds Promising, But We're Not Sold Yet

Michael Leavitt, secretary of the US Department of Health and Human Services, recently released a report (PDF here) on the state of personalized healthcare in America. In response, Rick Weiss at Science Progress has a thoughtful post about the concept of personalized medicine -- and the associated costs in implementing such a program. Based on the HHS report, he writes, "one can't help but conclude ... that it is going to be an uphill battle to justify some of the upfront costs of the personalized medicine revolution, given the many technical, political, and educational hurdles that stand between where we are and where we want to get." He describes a number of those hurdles -- electronic health records, physician education, privacy protection, and more -- but doesn't mince words about the current system: "Some kind of reform is clearly needed," he writes.


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.